Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-14

Clinical Trial Update: Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome [NA]

View source ↗

Summary

This clinical trial is evaluating the effects of chronic creatine and beta-hydroxy-beta-methylbutyrate supplementation on oxidative stress, inflammation, muscle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Creatine (creatine)
  • beta-hydroxy-beta-methylbutyrate (HMB) (beta-hydroxy-beta-methylbutyrate)

Snippet

Sponsor: Universidad de Burgos | Conditions: Down Syndrome (DS), Supplementation | NA | Status: RECRUITING